BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32341584)

  • 1. Risk of Gynecologic Cancer as Second versus First Primary Cancer in Japan.
    Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
    Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical statistics of gynecologic cancers in Japan.
    Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
    J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.
    Nagase S; Ohta T; Takahashi F; Enomoto T;
    J Obstet Gynaecol Res; 2019 Feb; 45(2):289-298. PubMed ID: 30426591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
    Heudel P; Chabaud S; Perol D; Flechon A; Fayette J; Combemale P; Tredan O; Desseigne F; de la Fouchardiere C; Boyle H; Perol M; Bachelot T; Cassier P; Avrillon V; Terret C; Michallet AS; Neidhardt-Berard EM; Nicolas-Virelizier E; Dufresne A; Belhabri A; Brahmi M; Lebras L; Nicolini F; Sarabi M; Rey P; Bonneville-Levard A; Rochefort P; Provensal AM; Eberst L; Assaad S; Swalduz A; Saintigny P; Toussaint P; Guillermin Y; Castets M; Coutzac C; Meeus P; Dupré A; Durand T; Crochet H; Fervers B; Gomez F; Rivoire M; Gregoire V; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Lasset C; Chvetzoff G; Mehlen P; Beaupère S; Zrounba P; Ray-Coquard I; Blay JY
    ESMO Open; 2021 Feb; 6(1):100044. PubMed ID: 33516148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for colorectal cancer after gynecologic cancer.
    Weinberg DS; Newschaffer CJ; Topham A
    Ann Intern Med; 1999 Aug; 131(3):189-93. PubMed ID: 10428735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of second primary cancers in North Portugal-a population-based study.
    Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
    J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonbreast second malignancies after treatment of primary breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer incidence and risk factors in patients with salivary gland cancers.
    Kwon M; Lee JI; Roh JL; Cho KJ; Choe J; Choi SH; Nam SY; Kim SY
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):118-23. PubMed ID: 24370632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second primary malignancies following gynecological tumours in Saarland, Germany, 1968-1987.
    Brenner H; Siegle S; Stegmaier C; Ziegler H
    J Cancer Res Clin Oncol; 1993; 119(3):179-83. PubMed ID: 8418092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for second primary tumours in breast cancer survivors.
    Sánchez L; Lana A; Hidalgo A; Rodríguez JM; Del Valle Mdel O; Cueto A; Folgueras MV; Belyakova E; Comendador MA; López ML
    Eur J Cancer Prev; 2008 Oct; 17(5):406-13. PubMed ID: 18714181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicide rates among patients with first and second primary cancer.
    Jiang Y; Wang Y; Cheng X; Zhou Z; Wang J; Yu H; Yao G; Lu Z; Chen X; Yan S; Zhao F
    Epidemiol Psychiatr Sci; 2023 Sep; 32():e57. PubMed ID: 37711033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
    Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
    Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.
    Morais S; Antunes L; Bento MJ; Lunet N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):85-91. PubMed ID: 28843176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
    Michaan N; Gortzak-Uzan L; Grisario D; Laskov I
    Int J Gynaecol Obstet; 2018 Aug; 142(2):176-181. PubMed ID: 29742279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009.
    Saito T; Takahashi F; Katabuchi H;
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1667-1677. PubMed ID: 28892220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis.
    Rose Ragin CC; Taioli E
    Head Neck; 2008 Jan; 30(1):58-66. PubMed ID: 17657793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
    Jalil NA; Zin AA; Othman NH
    Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of chronic diseases contributes to the occurrence risk factors for gynecological cancers in Japan.
    Okamoto K; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Ogawa C; Masuyama H
    Mol Clin Oncol; 2020 Apr; 12(4):336-342. PubMed ID: 32190316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice.
    Rasmussen LA; Jensen H; Virgilsen LF; Falborg AZ; Møller H; Vedsted P
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13123. PubMed ID: 31231898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.